Premenopsal women dx'ed w/early HR+ HER2- disease w/high recurrence risk benefit from Aromasin + ovarian suppression https://t.co/wHyNg9oil5
— Breastcancer.org (@Breastcancerorg) April 22, 2016
from Twitter https://twitter.com/andreahttn
April 23, 2016 at 04:55PM
via IFTTT
No comments:
Post a Comment